Sort
141,003 grants matching “cytokine”
Conformational regulation of TGF-β activation by integrin αvβ6
$783,795Stephen L Nishimura · University Of California, San Francisco · R01 · FY2024 · HL
ADMINISTRATIVE CORE, CENTER DIRECTOR, ENRICHMENT PROGRAM
$783,750Ramnik J Xavier · Massachusetts General Hospital · P30 · FY2011 · DK
MACROPHAGES, OXIDATION, AND ENDOMETRIOSIS
$783,721Emory University · P01 · FY2001 · HD
Immune based interventions for HIV eradication
$783,714Mirko Paiardini · Emory University · R01 · FY2019 · AI
A Novel Glycosaminoglycan-Based Therapeutic for Chronic Rhinosinusitis
$783,698Abigail Pulsipher · Glycomira, Llc · R44 · FY2020 · AI
Natural History of C. trachomatis urogenital and rectal infections
$783,622Deborah Anne Dean · University Of California, San Francisco · R01 · FY2024 · AI
Chemoenzymatic glycan editing for deciphering biological functions of glycans
$783,616Peng Wu · Scripps Research Institute, The · R35 · FY2021 · GM
The Impact of Tolerance in the Newborn on Lentiviral Infection
$783,538Joseph M McCune · University Of California, San Francisco · R01 · FY2010 · AI
Testing practical microbicides in macaques
$783,535Ronald S. Veazey · Weill Medical Coll Of Cornell Univ · U19 · FY2010 · AI
Hydrogel-enabled self-assembled human brain organoids for neurotoxicity applications
$783,533Connie S Lebakken · Stem Pharm, Inc. · R44 · FY2022 · ES
Mechanisms of myocarditis and progressive cardiac fibrosis in chronic Trypanosoma cruzi infection.
$783,532Kathryn Marie Jones · Baylor College Of Medicine · R01 · FY2022 · AI
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis
$783,413John R. Chan · Rbhs-New Jersey Medical School · R01 · FY2022 · AI
Role of Th17 in Severe and Recurrent C. difficile Infection
$783,404William A Petri · University Of Virginia · R01 · FY2023 · AI
MOLECULAR MECHANISMS OF THE IGE ALLERGIC RESPONSE
$783,382Children'S Hospital Boston · P01 · FY2001 · AI
Systems Biology of Mumps Vaccine Response
$783,307Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2021 · AI
Establishment of a causal link between AD and L1 retrotransposons
$783,212Alysson R. Muotri · University Of California, San Diego · R01 · FY2024 · AG
Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies
$783,201Deanna L Kelly · University Of Maryland Baltimore · R01 · FY2018 · MH
Maternal and Infant Microbiome Determinants of Brain and Behavioral Development
$783,172Christopher L. Coe · University Of Wisconsin-Madison · R33 · FY2016 · MH
Cooperative Research Partnership for an Amebic Colitis Vaccine
$783,068William A Petri · University Of Virginia · U01 · FY2008 · AI
Identification and Characterization of Microbial Metabolites in Immunity
$783,068Ramnik J Xavier · Broad Institute, Inc. · R01 · FY2022 · AI
Pre-Clinical Immunogenicity Testing of Chimp Adenovirus Vectors
$783,014Hildegund C. J. Ertl · Wistar Institute · U19 · FY2007 · AI
Biological Vulnerability to Chlamydia trachomatis in Adolescents and Young Women: the Complex Intersection of Cervicovaginal Microbiome, Cervical Maturation, and Mucosal Immunity
$782,960Loris Y. Hwang · University Of California Los Angeles · R01 · FY2019 · AI
Biobehavioral predictors of fatigue in newly-diagnosed breast cancer patients
$782,956Julienne E Bower · University Of California Los Angeles · R01 · FY2016 · CA
Transcriptomic Signatures of Influenza Vaccine Responses
$782,918Gregory A. Poland · Mayo Clinic Rochester · R01 · FY2021 · AI
Novel IL-23 inhibitor for the treatment of alcohol associated liver disease
$782,852Rohit Loomba · University Of California, San Diego · U01 · FY2020 · AA